Mr. West is CEO and president of Intersect ENT, a commercial stage drug-device company that agreed to a deal in August to be acquired by Medtronic for $1.1 billion.
Prior to Intersect ENT, he served as division president of diagnostic solutions at women’s health company Hologic.
Over a 23-year career at Johnson & Johnson, Mr. West held several domestic and international leadership roles, ending his tenure at the company in 2014 as worldwide vice president of strategy and business development for its diabetes solutions business.
Mr. West has an MBA in marketing and strategic management from the Wharton School of the University of Pennsylvania in Philadelphia.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
